ClinicalTrials.govpublic full text
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
chronic lymphocytic leukemia, b-cell lymphoma-2 inhibitor, bruton tyrosine kinase inhibitor, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 801248
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.